The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

We recently compiled a list of the 10 Best Cancer Stocks to Buy for the Long Term. Novartis AG is also one of the best cancer stocks to buy for the long term.

On May 7, NVS began construction on a 46,000-square-foot radioligand therapy manufacturing facility in Denton, Texas. The project is part of the company’s broader $23 billion commitment to expanding U.S.-based manufacturing and research capacity. This site marks NVS’s first production facility in Texas and is intended to strengthen access to radioligand therapies for patients in the southern United States. It also becomes the fifth such facility in the country.

On April 30, Novartis AG (NYSE:NVS) outlined plans for a 56,200-square-foot manufacturing site in Morrisville, North Carolina. The facility will focus on producing active pharmaceutical ingredients used in solid oral medicines such as tablets and capsules, as well as supporting RNA-based therapies.

This project represents the seventh new site announced within a year under the company’s $23 billion investment program aimed at expanding U.S. manufacturing and research capabilities. Once completed, it will increase NVS’s footprint in North Carolina to five facilities distributed across three different locations, strengthening its regional production network.

Novartis AG (NYSE:NVS) is a global healthcare company based in Basel and a major player in oncology. It develops targeted therapies, cell and gene therapies, and radioligand treatments for cancers like breast and prostate cancer, with a strong focus on precision medicine and expanding its manufacturing capabilities.

While we acknowledge the potential of NVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 AI-Powered Biotech Stocks to Buy Right Now  and 9 Most Undervalued Healthcare Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.